<DOC>
	<DOCNO>NCT01125527</DOCNO>
	<brief_summary>This study evaluate safety immunogenicity single dose two commercially available vaccine use prevent Haemophilus influenzae type b infection child 13-59 month age .</brief_summary>
	<brief_title>Immunogenicity Safety Monovalent Glycoprotein-Conjugated ( Diptheria Toxin -CRM197 ) Hib Vaccine 13-59 Months Old Healthy Children</brief_title>
	<detailed_description />
	<mesh_term>Diphtheria</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<mesh_term>Krestin</mesh_term>
	<criteria>Infants 1359 month age . Prior Hib vaccine administration . History serious reaction ( ) follow vaccination . Any vaccination within 7 day study vaccination . Known suspected immune impairment . Premature ( 37th week gestation ) birth weight less 2500g For additional entry criterion please refer protocol .</criteria>
	<gender>All</gender>
	<minimum_age>13 Months</minimum_age>
	<maximum_age>59 Months</maximum_age>
	<verification_date>December 2011</verification_date>
	<keyword>Haemophilus influenzae type b ( Hib )</keyword>
	<keyword>Vaccine</keyword>
	<keyword>Anti PRP antibody</keyword>
</DOC>